Practical Guidelines for the Evaluation and Management of Drug Hypersenstivity: General Concepts

Comprehensive practical guidance for the evaluation and management of patients with drug allergy and hypersensitivity are lacking. This activity will support learners as they review the supplement of the same title, published in the Journal of Allergy and Clinical Immunology: In Practice in October 2020. The supplement draws primarily from evidence-based published literature and incorporates experience from experts to fill current knowledge gaps related to drug allergy and hypersensitivity, and helping allergist/immunologists to expand their scope of practice.

Target Audience

  • Allergist/Immunologists
  • Allergy/Immunology Fellows-in-Training
  • Nurses and other Allied Health providers practicing in allergy/immunology settings
  • Other physicians treating patients with allergic and immunologic conditions

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Classify drug hypersensitivity reactions and identify risk factors associated with these reactions
  • Evaluate a patient presenting with drug hypersensitivity reactions and know the in vivo and in vitro diagnostic tools that are most appropriate for that patient
  • Identify the best approach to the management of a patient presenting with a history of a drug hypersensitivity reaction, including continued avoidance, graded challenge, desensitization, or direct delabeling.
Summary
Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.
Course opens: 
02/08/2021
Course expires: 
02/01/2023
Cost:
$0.00
Rating: 
0
Course Authors

Ana Dioun Broyles, MD FAAAAI
Boston Children's Hospital, Boston MA

Aleena Banerji, MD FAAAAI
Massachusetts General Hospital, Boston MA

Mariana Castells, MD FAAAAI
Brigham and Women's Hospital, Boston MA

Course authors disclosed no relevant financial relationships.

CME Reviewer

Thomas P. Miller, MD FAAAAI
Allergy Associates of Western Michigan PC, Grandville, MI

Dr. Miller disclosed no relevant financial relationships.

 


AAAAI DISCLOSURE POLICY

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on February 15, 2022. Requests to claim credit on or after February 16, 2022 will be denied.

AAAAI PRIVACY POLICY

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org

QUESTIONS

Activity-related questions should be directed to cme@aaaai.org.

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.